| Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018 | 2269 | 2018 |
| Non-coding recurrent mutations in chronic lymphocytic leukaemia XS Puente, S Beà, R Valdés-Mas, N Villamor, J Gutiérrez-Abril, ... Nature 526 (7574), 519-524, 2015 | 1031 | 2015 |
| Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations D Tamborero, C Rubio-Perez, J Deu-Pons, MP Schroeder, A Vivancos, ... Genome medicine 10, 1-8, 2018 | 497 | 2018 |
| In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities C Rubio-Perez, D Tamborero, MP Schroeder, AA Antolín, J Deu-Pons, ... Cancer cell 27 (3), 382-396, 2015 | 340 | 2015 |
| Pan-cancer Analysis of Whole Genomes ITPCAWG Consortium Nature 578, 2020 | 302* | 2020 |
| A pan-cancer landscape of interactions between solid tumors and infiltrating immune cell populations D Tamborero*, C Rubio-Perez*, F Muiños, R Sabarinathan, JM Piulats, ... Clinical Cancer Research 24 (15), 3717-3728, 2018 | 280 | 2018 |
| Independent component analysis uncovers the landscape of the bladder tumor transcriptome and reveals insights into luminal and basal subtypes A Biton, I Bernard-Pierrot, Y Lou, C Krucker, E Chapeaublanc, ... Cell reports 9 (4), 1235-1245, 2014 | 215 | 2014 |
| LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy M Pascual-García, E Bonfill-Teixidor, E Planas-Rigol, C Rubio-Perez, ... Nature communications 10 (1), 2416, 2019 | 188 | 2019 |
| Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets K Karube, A Enjuanes, I Dlouhy, P Jares, D Martín-García, F Nadeu, ... Leukemia 32 (3), 675-684, 2018 | 188 | 2018 |
| Molecular diagnosis of diffuse gliomas through sequencing of cell-free circulating tumor DNA from cerebrospinal fluid F Martínez-Ricarte, R Mayor, E Martínez-Sáez, C Rubio-Pérez, E Pineda, ... Clinical Cancer Research 24 (12), 2812-2819, 2018 | 170 | 2018 |
| Single-cell transcriptional changes associated with drug tolerance and response to combination therapies in cancer AF Aissa, AB Islam, MM Ariss, CC Go, AE Rader, RD Conrardy, AM Gajda, ... Nature communications 12 (1), 1628, 2021 | 164 | 2021 |
| A single-cell tumor immune atlas for precision oncology P Nieto, M Elosua-Bayes, JL Trincado, D Marchese, R Massoni-Badosa, ... Genome research 31 (10), 1913-1926, 2021 | 119 | 2021 |
| NK Cell Infiltrates and HLA Class I Expression in Primary HER2+ Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival A Muntasell, F Rojo, S Servitja, C Rubio-Perez, M Cabo, D Tamborero, ... Clinical Cancer Research 25 (5), 1535-1545, 2019 | 107 | 2019 |
| Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas S Bobillo, M Crespo, L Escudero, R Mayor, P Raheja, C Carpio, ... Haematologica 106 (2), 513, 2021 | 106 | 2021 |
| Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma L Escudero, A Llort, A Arias, A Diaz-Navarro, F Martínez-Ricarte, ... Nature communications 11 (1), 5376, 2020 | 96 | 2020 |
| Severe SARS-CoV-2 placenta infection can impact neonatal outcome in the absence of vertical transmission FM Cribiù, R Erra, L Pugni, C Rubio-Perez, L Alonso, S Simonetti, ... The Journal of Clinical Investigation 131 (6), 2021 | 85 | 2021 |
| A CT-based radiomics signature is associated with response to immune checkpoint inhibitors in advanced solid tumors M Ligero, A Garcia-Ruiz, C Viaplana, G Villacampa, MV Raciti, J Landa, ... Radiology 299 (1), 109-119, 2021 | 74 | 2021 |
| The DYRK family of kinases in cancer: molecular functions and therapeutic opportunities J Boni, C Rubio-Perez, N López-Bigas, C Fillat, S de la Luna Cancers 12 (8), 2106, 2020 | 72 | 2020 |
| OncodriveROLE classifies cancer driver genes in loss of function and activating mode of action MP Schroeder, C Rubio-Perez, D Tamborero, A Gonzalez-Perez, ... Bioinformatics 30 (17), i549-i555, 2014 | 68 | 2014 |
| The whole-genome panorama of cancer drivers R Sabarinathan, O Pich, I Martincorena, C Rubio-Perez, M Juul, J Wala, ... BioRxiv, 190330, 2017 | 56 | 2017 |